Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a light-activated antimicrobial therapy intended to prevent surgical site infections; the study is currently Active, Not Recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Light-Activated Antimicrobial Therapy (Ondine) (Light-activated antimicrobial therapy)

Snippet

Sponsor: Ondine Biomedical Inc. | Conditions: Surgical Site Infections, Surgical Wound Infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING